Levocarnitine may improve the survival of patients with liver cirrhosis who undergo cell-free and concentrated ascites reinfusion therapy for refractory ascites

Hiromichi Kawaji, Akio Moriya, Teruya Nagahara, Yoshiaki Iwasaki, Masaharu Ando

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Levocarnitine may improve the survival of patients with liver cirrhosis who undergo cell-free and concentrated ascites reinfusion therapy for refractory ascites'. Together they form a unique fingerprint.

Medicine & Life Sciences